Tharimmune

Biotechnology company(THAR)

A propos de Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Communauté
Website
Étiquettes
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Aucun enregistrement

Membres de l'équipe

Mark Wendland
Mark Wendland

Chairman and CEO

Angela Radkowski
Angela Radkowski

COO

Investisseurs

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Détails du financement

Post-IPO(2025-11-03)
Montant€472,17M
Investisseurs
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Estimation--